In people with T2D, the activity of insulin receptors—a type of tyrosine kinase receptor—is reduced, not because of structural abnormalities or insulin binding affinity, but because of the metabolic disturbances present [5,20]. This evidence concerns the gene INS and type 2 diabetes mellitus.